{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:15:29Z","timestamp":1791202529821,"version":"4.2.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.mehy.2012.02.009","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T18:43:01Z","timestamp":1330972981000},"page":"675-681","source":"Crossref","is-referenced-by-count":47,"title":["Glutamate-based depression GBD"],"prefix":"10.1016","volume":"78","author":[{"given":"Dennis J.","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Sanacora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2012.02.009_b0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmcol"},{"key":"10.1016\/j.mehy.2012.02.009_b0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.mehy.2011.06.021","article-title":"Stressor-induced NMDAR dysfunction as a unifying hypothesis of the aetiology, pathogenesis and comorbidity of clinical depression","volume":"77","author":"Marsden","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2012.02.009_b0015","doi-asserted-by":"crossref","unstructured":"Niciua MJ, Kelmendic B, Sanacora G. Overview of glutamatergic neurotransmission in the nervous system. Pharmacol Biochem Behav, in Press, uncorrected proof. doi:10.1016\/j.pbb.2011.08.008.","DOI":"10.1016\/j.pbb.2011.08.008"},{"key":"10.1016\/j.mehy.2012.02.009_b0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.mehy.2012.02.009_b0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187152707780363267","article-title":"The NMDA receptor as a therapeutic target in major depressive disorder","volume":"6","author":"Pittenger","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.mehy.2012.02.009_b0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2012.02.009_b0035","doi-asserted-by":"crossref","first-page":"e8566","DOI":"10.1371\/journal.pone.0008566","article-title":"Acute stress increases depolarization-evoked glutamate release in the Rat prefrontal\/frontal cortex: the dampening action of antidepressants","volume":"5","author":"Musazzi","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.mehy.2012.02.009_b0040","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1111\/j.1460-9568.2007.05560.x","article-title":"Acute stress-mediated increases in extracellular glutamate levels in the rat amygadala: differential effects of antidepressant treatment","volume":"25","author":"Reznikov","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00023210-200822010-00002","article-title":"Neurobiological and clinical effects of the antidepressant tianeptine","volume":"22","author":"Kasper","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.mehy.2012.02.009_b0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/mp.2009.80","article-title":"The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation","volume":"15","author":"McEwen","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2012.02.009_b0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2008.09.026","article-title":"The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats","volume":"598","author":"Kotlinska","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2012.02.009_b0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0741-8329(99)00045-2","article-title":"Effects of NMDA antagonists on ethanol withdrawal induced \u201canxiety\u201d in the elevated plus maze","volume":"19","author":"Gatch","year":"1999","journal-title":"Alcohol"},{"key":"10.1016\/j.mehy.2012.02.009_b0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0166-2236(02)02272-5","article-title":"NMDA-receptor trafficking and targeting: implications for synaptic transmission and plasticity","volume":"25","author":"Carroll","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/mp.2008.106","article-title":"Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole","volume":"15","author":"Banasr","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0080","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1152\/jn.00282.2010","article-title":"Bidirectional neuron \u2013 Glia interactions triggered by deficiency of glutamate uptake at spinal sensory synapses","volume":"104","author":"Nie","year":"2010","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.mehy.2012.02.009_b0085","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signaling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1995.65010268.x","article-title":"Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats","volume":"65","author":"Lowy","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2012.02.009_b0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","article-title":"Glutamate and depression: clinical and preclinical studies","volume":"1003","author":"Paul","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.mehy.2012.02.009_b0100","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0105","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2012.02.009_b0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-3223(00)00874-X","article-title":"Differential limbic\u2013cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders","volume":"48","author":"Liotti","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrd2217","article-title":"How can drug discovery for psychiatric disorders be improved?","volume":"6","author":"Agid","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mehy.2012.02.009_b0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"Rota","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0125","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archgenpsychiatry.2007.37","article-title":"Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study","volume":"65","author":"Deakin","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"2004","key":"10.1016\/j.mehy.2012.02.009_b0140","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.tins.2004.10.008","article-title":"Astrocytic control of glutamatergic activity: astrocytes as stars of the show","volume":"27","author":"Hertz","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1517\/14728220902926127","article-title":"Excitatory amino acid transporters as potential drug targets","volume":"13","author":"Bunch","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.mehy.2012.02.009_b0150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.biopsych.2008.06.008","article-title":"Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors","volume":"64","author":"Banasr","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2004.11.014","article-title":"TNF-alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition","volume":"1034","author":"Zou","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2012.02.009_b0160","doi-asserted-by":"crossref","first-page":"13290","DOI":"10.1073\/pnas.95.22.13290","article-title":"Glial reduction in the subgenual prefrontal cortex in mood disorders","volume":"95","author":"Ongur","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2012.02.009_b0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/187152707780619326","article-title":"Gliogenesis and glial pathology in depression","volume":"6","author":"Rajkowska","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.mehy.2012.02.009_b0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.mehy.2012.02.009_b0175","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"MTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.02.009_b0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0185","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00702-008-0128-2","article-title":"Lack of NMDA\u2013AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test","volume":"115","author":"Dybala","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.mehy.2012.02.009_b0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.mp.4001469","article-title":"Functional but not structural subgenual prefrontal cortex abnormalities in melancholia","volume":"9","author":"Pizzagalli","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0195","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1176\/appi.ajp.157.7.1095","article-title":"Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness","volume":"157","author":"Schatzberg","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0200","unstructured":"Segal S, Tetens J, Kegeles L, et al., The effects of local high frequency electrical stimulation on monoamine efflux in the subgenual cingulate cortex (Brodmann Area 25) and its striatal and thalamic projection regions, 37th annual meeting of the Society for Neuroscience 2007 Poster 267.22\/W1."},{"key":"10.1016\/j.mehy.2012.02.009_b0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biopsych.2008.08.014","article-title":"Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine","volume":"65","author":"Salvadore","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0210","doi-asserted-by":"crossref","unstructured":"Salvadore G, Cornwell BR, Sambataro F, et al., Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine, Neuropsychopharmacology March 2010, pp. 1\u20138, Advanced online publication.","DOI":"10.1038\/npp.2010.24"},{"key":"10.1016\/j.mehy.2012.02.009_b0215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","article-title":"Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity","volume":"66","author":"Harrison","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn3138","article-title":"The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission","volume":"13","author":"Popoli","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0225","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.mp.4002006","article-title":"The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression","volume":"12","author":"M\u00fcller","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(91)90559-C","article-title":"Murine brain macrophages induce NMDA receptor mediated neurotoxicity by secreting glutamate","volume":"133","author":"Piani","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2012.02.009_b0235","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000026433","article-title":"Cytokine effects on glutamate uptake by human astrocytes","volume":"7","author":"Hu","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.mehy.2012.02.009_b0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2009.01.040","article-title":"Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis","volume":"1263","author":"Carmen","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2012.02.009_b0245","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mcn.2010.09.001","article-title":"TNF-\u03b1 potentiates glutamate-induced spinal cord motoneuron death via NF-\u03baB","volume":"46","author":"Tolosa","year":"2011","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0017837","article-title":"Leukocyte telomer length in major depression: correlations with chronicity, inflammation and oxidative stress\u2014Preliminary findings","volume":"6","author":"Wolkowitz","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2012.02.009_b0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2003-45131","article-title":"Neurotransmitter changes by interferon-alpha and therapeutic implications","volume":"36","author":"Schaefer","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0260","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archpsyc.63.3.283","article-title":"Onset of major depression associated with acute coronary syndromes","volume":"63","author":"Glassman","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0265","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/070674370605101202","article-title":"Recent evidence linking coronary heart disease and depression","volume":"51","author":"Frasure-Smith","year":"2006","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0270","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.297.4.367","article-title":"The CREATE Investigators. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial","volume":"297","author":"Lesp\u00e9rance","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2012.02.009_b0275","unstructured":"L.R. Wulsin, Treating the Aching Heart, Vanderbilt University Press, 2007."},{"key":"10.1016\/j.mehy.2012.02.009_b0280","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1192\/bjp.bp.107.035360","article-title":"Does treating depression improve survival after acute coronary syndrome?","volume":"190","author":"Carney","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.mehy.2012.02.009_b0285","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1365-2362.2003.01186.x","article-title":"Immune activation and degradation of tryptophan in coronary heart disease","volume":"33","author":"Wirleitner","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.mehy.2012.02.009_b0290","first-page":"11","article-title":"The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-\u03b1-induced depression","volume":"29","author":"Wichers","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0295","doi-asserted-by":"crossref","first-page":"26992","DOI":"10.1074\/jbc.M503555200","article-title":"Structural characterization of the intermolecular interactions of synapse-associated protein-97 with the NR2B subunit of the N-Methyl-d-aspartate receptors","volume":"280","author":"Wang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2012.02.009_b0300","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/rheumatology\/40.12.1327","article-title":"The burden of depression in patients with rheumatoid arthritis","volume":"40","author":"Dickens","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.mehy.2012.02.009_b0305","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00006842-200201000-00008","article-title":"Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis","volume":"64","author":"Dickens","year":"2002","journal-title":"Psychosom Med"},{"key":"10.1016\/j.mehy.2012.02.009_b0310","first-page":"790","article-title":"Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis","volume":"20","author":"Katz","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2012.02.009_b0315","first-page":"1013","article-title":"Co-morbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis","volume":"32","author":"Ang","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2012.02.009_b0320","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/keg082","article-title":"Suicides in persons suffering from rheumatoid arthritis","volume":"42","author":"Timonen","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.mehy.2012.02.009_b0325","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/bmj.321.7271.1290","article-title":"Suicidal ideation in patients with rheumatoid arthritis. Research may help identify patients at high risk","volume":"321","author":"Treharne","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2012.02.009_b0330","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2006.02.009","article-title":"Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro","volume":"535","author":"Parada-Turskaa","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2012.02.009_b0335","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.59.6.455","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatooid arthritis or osterarthritis","volume":"59","author":"Yoshihara","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2012.02.009_b0340","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/art.22829","article-title":"Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors","volume":"56","author":"Flood","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2012.02.009_b0345","doi-asserted-by":"crossref","unstructured":"Domenici E, Will\u00e9 DR, Tozzi F, et al., Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections, PLoS ONE 2010;5:1\u201312. www.plosone.org.","DOI":"10.1371\/journal.pone.0009166"},{"key":"10.1016\/j.mehy.2012.02.009_b0350","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.psy.0000204851.15499.fc","article-title":"Co-morbid depression, chronic pain, and disability in primary care","volume":"68","author":"Arnow","year":"2006","journal-title":"Psychosom Med"},{"key":"10.1016\/j.mehy.2012.02.009_b0355","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.psy.48.5.394","article-title":"Gender differences in depression and chronic pain conditions in a national epidemiologic survey","volume":"48","author":"Munce","year":"2007","journal-title":"Psychosomatics"},{"key":"10.1016\/j.mehy.2012.02.009_b0360","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.semcdb.2006.10.008","article-title":"Glutamate receptors and pain","volume":"17","author":"Bleakman","year":"2006","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.mehy.2012.02.009_b0365","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1359-6446(01)02138-9","article-title":"Glutamate receptors and persistent pain: targeting forebrain NR2B subunits","volume":"7","author":"Zhuo","year":"2002","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.mehy.2012.02.009_b0370","first-page":"4","article-title":"Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review","volume":"4","author":"Buchheit","year":"2011","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.mehy.2012.02.009_b0375","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1526-4637.2011.01220.x","article-title":"A systematic review of ketamine as an analgesic agent in adult burn injuries","volume":"12","author":"McGuinness","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.mehy.2012.02.009_b0380","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1213\/01.ANE.0000086618.28845.9B","article-title":"Ketamine in chronic pain management: an evidence-based review","volume":"97","author":"Hocking","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.mehy.2012.02.009_b0385","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/diacare.27.5.1066","article-title":"Diabetes, depression and quality of life: a population study","volume":"27","author":"Goldney","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2012.02.009_b0390","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00207511","article-title":"Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity","volume":"74","author":"Hack","year":"1996","journal-title":"J Mol Med"},{"key":"10.1016\/j.mehy.2012.02.009_b0395","first-page":"3109","article-title":"Diabetes-induced dysfunction of the glutamate transporter in retinal muller cells","volume":"43","author":"Li","year":"2002","journal-title":"IOVS"},{"key":"10.1016\/j.mehy.2012.02.009_b0400","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2012.02.009_b0405","unstructured":"Yoon YH, Yoo AM, Koh JY, Riluzole inhibits retinal endothelial cell proliferation in vivo and in vitro, Invest Ophthalmol Vis Sci 2004; 45:E-Abstract 454."},{"key":"10.1016\/j.mehy.2012.02.009_b0410","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200009073431007","article-title":"Drug therapy: treatment of acute ischemic stroke","volume":"343","author":"Brott","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2012.02.009_b0415","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.ne.13.030190.001131","article-title":"The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death","volume":"13","author":"Choi","year":"1990","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0420","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1161\/01.STR.26.11.2187","article-title":"Massive persistent release of excitatory amino acids following human occlusive stroke","volume":"26","author":"Bullock","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2012.02.009_b0425","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.STR.28.4.708","article-title":"Duration of glutamate release after acute ischemic stroke","volume":"28","author":"D\u00e1valos","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2012.02.009_b0430","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0003-9993(97)90433-0","article-title":"Post-stroke depression: an examination of the literature","volume":"78","author":"Gordon","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.mehy.2012.02.009_b0435","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuint.2007.04.026","article-title":"Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies","volume":"50","author":"Hazell","year":"2007","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mehy.2012.02.009_b0440","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nn2004","article-title":"Astrocyte metabolism and signaling during brain ischemia","volume":"10","author":"Rossi","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0445","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1176\/jnp.9.4.556","article-title":"Major and minor depression in Alzheimer\u2019s disease: prevalence and impact","volume":"9","author":"Lyketsos","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0166-2236(87)90025-7","article-title":"Glutamate dysfunction in Alzheimer\u2019s disease: an hypothesis","volume":"10","author":"Maragos","year":"1987","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0455","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0404.2004.00292.x","article-title":"Mortality in Parkinson\u2019s disease and its association with dementia and depression","volume":"110","author":"Hughes","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.mehy.2012.02.009_b0460","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002512-200320050-00006","article-title":"Glutamate receptors and Parkinson\u2019s disease: opportunities for intervention","volume":"20","author":"Marino","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.mehy.2012.02.009_b0465","first-page":"344","article-title":"Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease","volume":"50","author":"Benabid","year":"1987","journal-title":"Appl Neurophysiol"},{"key":"10.1016\/j.mehy.2012.02.009_b0470","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1056\/NEJMoa0907083","article-title":"Pallidal versus subthalamic deep-brain stimulation for Parkinson\u2019s disease","volume":"362","author":"Follett","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2012.02.009_b0475","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.neuropsych.19.4.441","article-title":"Psychopathology in verified Huntington\u2019s disease gene carriers","volume":"19","author":"van Duijn","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.mehy.2012.02.009_b0480","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","article-title":"Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington\u2019s Disease \u2013 An in-situ hybridization study","volume":"56","author":"Arzberger","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.mehy.2012.02.009_b0485","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2012.02.009_b0490","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/brain\/awq047","article-title":"Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington\u2019s disease","volume":"133","author":"Thu","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2012.02.009_b0495","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2012.02.009_b0500","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/art.1780390311","article-title":"Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness","volume":"39","author":"Aaron","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mehy.2012.02.009_b0505","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(92)90265-D","article-title":"Co-morbidity of fibromyalgia with medical and psychiatric disorders","volume":"92","author":"Hudson","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2012.02.009_b0510","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11916-007-0216-2","article-title":"Sensitization, glutamate, and the link between migraine and fibromyalgia","volume":"11","author":"Sarchielli","year":"2007","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.mehy.2012.02.009_b0515","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1345\/aph.10254","article-title":"Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins","volume":"35","author":"Smith","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.mehy.2012.02.009_b0520","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009749509095181","article-title":"Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine, and ketamine","volume":"24","author":"S\u00f6rensen","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.mehy.2012.02.009_b0525","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0333102498018S2111","article-title":"Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-d-aspartate-mediated neuronal plasticity: their common clues","volume":"18","author":"Nicolodi","year":"1998","journal-title":"Cephalalgia"},{"key":"10.1016\/j.mehy.2012.02.009_b0530","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0304-3959(99)00308-5","article-title":"Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients","volume":"85","author":"Nielsen","year":"2000","journal-title":"Pain"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T23:09:02Z","timestamp":1561417742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987712000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0306987712000758"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2012.02.009","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}